Back to Clinical Trials Overview

Your search for "Infectious Diseases" returned 18 results:


Characterization of Acute HCV Infection
Principal Investigator(s): Fierer, Daniel S

Management Practices and the Risk of Infection Following Cardiac Surgery
Principal Investigator(s): Gelijns, Annetine

Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV
Principal Investigator(s): David Ferris

A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
Principal Investigator(s): Ponni Perumalswami

The Epidemiology of Ventricular Assist Device-Related Infections
Principal Investigator(s): Parides, Michael

Evaluation of HepCure Toolkit to Improve Harvoni Adherence
Principal Investigator(s): Jeffrey Weiss

The effect of non-ulcerative sexually transmitted infections on cervico-vaginal microbes and cervico-vaginal immune response
Principal Investigator(s): Sperling, Rhoda S, MD

Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM Followed by Electroporation in Select Nucleos(t)ide Analogue-treated, Chronic Hepatitis B Patients
Principal Investigator(s): Douglas Dieterich

A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects with Genotype 1, 4, 5 and 6 Chronic HCV Infection Who are on Dialysis for End Stage Renal Disease
Principal Investigator(s): Ritu Agarwal

Efficacy & Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock
Principal Investigator(s): Oropello, John M

Intracellular Antivirals:New Direction in HIV Control
Principal Investigator(s): Simon, Viviana

Studies of Ocular Complications of AIDS
Principal Investigator(s): Jabs, Douglas A

A Long-Term Follow-up Study to Evaluate the Durability of Virologic Response and/or Viral Resistance Patterns of Subjects with Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical Trial
Principal Investigator(s): Ponni Perumalswami

A Long Term Follow-up Registry Study for Subjects Who Achieve A Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
Principal Investigator(s): Ponni Perumalswami

Consortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae (CRACKLE): a Prospective, Observational Cohort Study
Principal Investigator(s): Gopi Patel

Cervical, Anal & Oral HPV Persistence/Adolescent Girls
Principal Investigator(s): Diaz, Angela MD, MPH

An Open-Label Multicenter Study to Evaluate Long-term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ II)
Principal Investigator(s): Douglas Dieterich

A Phase 2 Randomized Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 in combination with Tenofovir Disoproxil Fumarate (TDF) for the treatment of subjects with chronic hepatitis B and who are currently not on treatment
Principal Investigator(s): Jennifer Leong